Correlation Between CRISPR Therapeutics and Paramount Global

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Paramount Global at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Paramount Global into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Paramount Global, you can compare the effects of market volatilities on CRISPR Therapeutics and Paramount Global and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Paramount Global. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Paramount Global.

Diversification Opportunities for CRISPR Therapeutics and Paramount Global

0.28

Correlation Coefficient

CRISPR Therapeutics  Paramount Global

Modest diversification

The 3 months correlation between CRISPR and Paramount is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Paramount Global in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Paramount Global and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Paramount Global. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Paramount Global has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Paramount Global go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Paramount Global

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 2.75 times more return on investment than Paramount Global. However, CRISPR Therapeutics is 2.75 times more volatile than Paramount Global. It trades about 0.01 of its potential returns per unit of risk. Paramount Global is currently generating about 0.0 per unit of risk. If you would invest  3,159  in CRISPR Therapeutics AG on October 26, 2024 and sell it today you would lose (31.00) from holding CRISPR Therapeutics AG or give up 0.98% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	90.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Paramount Global

CRISPR Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Paramount Global

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Paramount Global are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental drivers, Paramount Global may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with CRISPR Therapeutics and Paramount Global

The main advantage of trading using opposite CRISPR Therapeutics and Paramount Global positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Paramount Global can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Paramount Global will offset losses from the drop in Paramount Global's long position.

The idea behind CRISPR Therapeutics AG and Paramount Global pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.